STAAR Surgical Stock Price, News & Analysis (NASDAQ:STAA)

$15.15 +0.05 (+0.33 %)
(As of 02/20/2018 12:37 PM ET)
Previous Close$15.15
Today's Range$15.05 - $15.30
52-Week Range$8.95 - $17.60
Volume89,600 shs
Average Volume109,350 shs
Market Capitalization$623.64 million
P/E Ratio-378.75
Dividend YieldN/A
Beta1.25

About STAAR Surgical (NASDAQ:STAA)

STAAR Surgical logoSTAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). As of December 30, 2016, it sold its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:STAA
CUSIP85231230
Phone626-303-7902

Debt

Debt-to-Equity Ratio0.02%
Current Ratio2.24%
Quick Ratio1.72%

Price-To-Earnings

Trailing P/E Ratio-378.75
Forward P/E Ratio-378.75
P/E GrowthN/A

Sales & Book Value

Annual Sales$82.43 million
Price / Sales7.56
Cash FlowN/A
Price / CashN/A
Book Value$0.93 per share
Price / Book16.29

Profitability

Trailing EPS($0.04)
Net Income$-12,120,000.00
Net Margins-2.47%
Return on Equity-3.34%
Return on Assets-1.93%

Miscellaneous

Employees336
Outstanding Shares41,160,000

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) issued its quarterly earnings data on Thursday, November, 3rd. The medical instruments supplier reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.04) by $0.02. The medical instruments supplier earned $20.05 million during the quarter, compared to analysts' expectations of $20.70 million. STAAR Surgical had a negative return on equity of 3.34% and a negative net margin of 2.47%. STAAR Surgical's revenue for the quarter was up 6.9% compared to the same quarter last year. View STAAR Surgical's Earnings History.

When will STAAR Surgical make its next earnings announcement?

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Wednesday, February, 28th 2018. View Earnings Estimates for STAAR Surgical.

Where is STAAR Surgical's stock going? Where will STAAR Surgical's stock price be in 2018?

2 analysts have issued 1-year price targets for STAAR Surgical's stock. Their predictions range from $20.00 to $21.00. On average, they anticipate STAAR Surgical's share price to reach $20.50 in the next year. View Analyst Ratings for STAAR Surgical.

Who are some of STAAR Surgical's key competitors?

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the folowing people:

  • Caren L. Mason, President, Chief Executive Officer, Director (Age 63)
  • Deborah J. Andrews, Chief Financial Officer, Vice President (Age 59)
  • Hans-Martin Blickensdoerfer, Senior Vice President - Commercial Operations for Europe, Middle East, Africa, Latin America and China. (Age 52)
  • James E. Francese, Senior Vice President of North American and APAC (Age 51)
  • Keith Holliday Ph.D., Chief Technology Officer, Vice President (Age 54)
  • Surindra Mann, Vice President - Global Financial Planning and Analysis
  • William Walter Goodmen, Vice President - Global Human Resources (Age 60)
  • Jon K. Hayashida, Vice President - Global Clinical and Medical Affairs
  • Philippe Subrin, Vice President-ICL Manufacturing (Age 51)
  • Samuel J. Gesten, Vice President - Business Development, Chief Legal Officer and Secretary (Age 55)

Who owns STAAR Surgical stock?

STAAR Surgical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Palo Alto Investors LLC (8.50%), BlackRock Inc. (6.34%), Millennium Management LLC (1.12%), Cortina Asset Management LLC (1.10%), Renaissance Technologies LLC (0.77%) and Geode Capital Management LLC (0.67%). Company insiders that own STAAR Surgical stock include Broadwood Partners Lp, Hans-Martin Blickensdoerfer, Keith Holliday and Richard A Meier. View Institutional Ownership Trends for STAAR Surgical.

Who sold STAAR Surgical stock? Who is selling STAAR Surgical stock?

STAAR Surgical's stock was sold by a variety of institutional investors in the last quarter, including Cortina Asset Management LLC, Millrace Asset Group Inc., Metropolitan Life Insurance Co. NY, Creative Planning, Palo Alto Investors LLC, Rice Hall James & Associates LLC, Rhumbline Advisers and Bank of New York Mellon Corp. View Insider Buying and Selling for STAAR Surgical.

Who bought STAAR Surgical stock? Who is buying STAAR Surgical stock?

STAAR Surgical's stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Folger Hill Asset Management LP, Deutsche Bank AG, Two Sigma Investments LP, BlackRock Inc., Barrow Hanley Mewhinney & Strauss LLC, Two Sigma Advisers LP and Algert Global LLC. View Insider Buying and Selling for STAAR Surgical.

How do I buy STAAR Surgical stock?

Shares of STAAR Surgical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAAR Surgical stock can currently be purchased for approximately $15.15.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $623.64 million and generates $82.43 million in revenue each year. The medical instruments supplier earns $-12,120,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. STAAR Surgical employs 336 workers across the globe.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 1911 WALKER AVE, MONROVIA CA, 91016. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]


MarketBeat Community Rating for STAAR Surgical (STAA)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  202 (Vote Underperform)
Total Votes:  316
MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

STAAR Surgical (NASDAQ:STAA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.50
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $20.50$20.50$20.50$12.00
Price Target Upside: 25.77% upside25.77% upside25.77% upside2.13% upside

STAAR Surgical (NASDAQ:STAA) Consensus Price Target History

Price Target History for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/20/2017BenchmarkReiterated RatingBuy -> Buy$21.00N/AView Rating Details
11/17/2017Canaccord GenuityBoost Price TargetBuy$17.50 -> $20.00N/AView Rating Details
8/4/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
5/12/2016StephensDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 2/20/2016 forward)

Earnings

STAAR Surgical (NASDAQ:STAA) Earnings History and Estimates Chart

Earnings by Quarter for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ STAA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2018$0.03N/AView Earnings Details
11/8/2017Q3 2017$0.02$0.02$23.47 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.05)($0.01)$22.15 million$21.90 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.05)($0.05)$20.35 millionViewListenView Earnings Details
3/2/2017Q4 2016($0.02)$0.02$22.25 million$22.10 millionViewListenView Earnings Details
11/3/2016Q316($0.04)($0.02)$20.70 million$20.05 millionViewListenView Earnings Details
8/3/2016Q216($0.05)($0.05)$19.88 million$21.00 millionViewListenView Earnings Details
5/11/2016Q116($0.17)($0.01)$19.60 million$19.30 millionViewListenView Earnings Details
3/2/2016Q415($0.02)$0.01$19.11 million$20.90 millionViewListenView Earnings Details
10/28/2015Q315($0.04)($0.04)$17.87 million$18.80 millionViewListenView Earnings Details
7/29/2015Q2 2015($0.02)$18.20 million$18.66 millionViewN/AView Earnings Details
4/29/2015Q115($0.04)$0.03$17.85 million$18.90 millionViewListenView Earnings Details
2/25/2015Q414($0.05)($0.03)$16.60 million$16.60 millionViewListenView Earnings Details
10/30/2014Q314$0.02($0.04)$19.53 million$18.20 millionViewListenView Earnings Details
7/30/2014Q214$0.03$0.01$19.80 million$20.05 millionViewListenView Earnings Details
4/28/2014Q114$0.01$0.04$19.44 million$20.20 millionViewListenView Earnings Details
2/26/2014Q413$0.02$0.02$18.98 million$18.90 millionViewListenView Earnings Details
10/30/2013Q313$0.02$0.04$17.35 million$17.10 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.04$0.05$17.40 million$18.20 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.04$0.08$17.27 million$18.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.03$0.01$17.55 million$16.50 millionViewListenView Earnings Details
10/31/2012Q312$0.01$0.04$16.78 million$15.90 millionViewN/AView Earnings Details
8/1/2012$0.03$0.03ViewN/AView Earnings Details
5/2/2012$0.03$0.04ViewN/AView Earnings Details
3/6/2012Q4 2011$0.02$0.02ViewN/AView Earnings Details
10/24/2011Q3 2011$0.02$0.01ViewN/AView Earnings Details
8/2/2011Q2 2011$0.01$0.02ViewN/AView Earnings Details
5/3/2011Q1 2011$0.01ViewN/AView Earnings Details
3/1/2011Q4 2010$0.01($0.02)ViewN/AView Earnings Details
11/2/2010Q3 2010$0.01($0.03)ViewN/AView Earnings Details
8/3/2010Q2 2010($0.02)ViewN/AView Earnings Details
5/4/2010Q1 2010($0.01)($0.02)ViewN/AView Earnings Details
3/2/2010Q4 2009($0.03)($0.06)ViewN/AView Earnings Details
11/2/2009Q3 2009($0.03)($0.05)ViewN/AView Earnings Details
8/3/2009Q2 2009($0.01)($0.04)ViewN/AView Earnings Details
5/5/2009Q1 2009($0.05)$0.02ViewN/AView Earnings Details
3/16/2009Q4 2008($0.04)($0.12)ViewN/AView Earnings Details
10/28/2008Q3 2008($0.07)($0.08)ViewN/AView Earnings Details
7/30/2008Q2 2008($0.10)($0.09)ViewN/AView Earnings Details
5/6/2008Q1 2008($0.12)($0.30)ViewN/AView Earnings Details
3/6/2008Q4 2007($0.10)($0.15)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

STAAR Surgical (NASDAQ:STAA) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.04 EPS
Next Year EPS Consensus Estimate: $0.18 EPS

Dividends

Dividend History for STAAR Surgical (NASDAQ:STAA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

STAAR Surgical (NASDAQ STAA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.40%
Institutional Ownership Percentage: 78.66%
Insider Trades by Quarter for STAAR Surgical (NASDAQ:STAA)
Insider Trades by Quarter for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ STAA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2017Keith HollidayVPSell6,000$16.65$99,900.0045,969View SEC Filing  
12/9/2016Hans-Martin BlickensdoerferVPSell25,000$11.14$278,500.00137,380View SEC Filing  
6/29/2016Broadwood Partners LpMajor ShareholderBuy14,144$5.24$74,114.56View SEC Filing  
5/25/2016Broadwood Partners LpMajor ShareholderBuy77,842$5.16$401,664.72View SEC Filing  
5/24/2016Broadwood Partners LpMajor ShareholderBuy70,000$5.16$361,200.00View SEC Filing  
5/23/2016Broadwood Partners LpMajor ShareholderBuy3,138$5.24$16,443.12View SEC Filing  
5/20/2016Richard A MeierDirectorSell25,000$5.35$133,750.0027,149View SEC Filing  
5/17/2016Broadwood Partners LpMajor ShareholderBuy9,313$5.23$48,706.99View SEC Filing  
5/16/2016Broadwood Partners LpMajor ShareholderBuy336,210$5.49$1,845,792.90View SEC Filing  
2/9/2016Broadwood Partners LpMajor ShareholderBuy91,770$6.25$573,562.50View SEC Filing  
2/3/2016Broadwood Partners LpMajor ShareholderBuy121,599$6.40$778,233.60View SEC Filing  
2/1/2016Broadwood Partners LpMajor ShareholderBuy65,983$6.48$427,569.84View SEC Filing  
1/27/2016Broadwood Partners LpMajor ShareholderBuy239,013$6.63$1,584,656.19View SEC Filing  
1/26/2016Broadwood Partners LpMajor ShareholderBuy112,900$6.60$745,140.00View SEC Filing  
1/25/2016Broadwood Partners LpMajor ShareholderBuy81,752$6.74$551,008.48View SEC Filing  
1/20/2016Broadwood Partners LpMajor ShareholderBuy72,858$6.75$491,791.50View SEC Filing  
1/15/2016Broadwood Partners LpMajor ShareholderBuy135,725$6.73$913,429.25View SEC Filing  
1/11/2016Broadwood Partners LpMajor ShareholderBuy86,586$6.83$591,382.38View SEC Filing  
1/7/2016Broadwood Partners LpMajor ShareholderBuy267,047$6.95$1,855,976.65View SEC Filing  
1/4/2016Broadwood Partners LpMajor ShareholderBuy165,461$7.11$1,176,427.71View SEC Filing  
9/29/2015Broadwood Partners LpMajor ShareholderBuy311,099$7.08$2,202,580.92View SEC Filing  
8/25/2015Broadwood Partners LpMajor ShareholderBuy188,881$7.17$1,354,276.77View SEC Filing  
8/24/2015Caren L MasonCEOBuy10,000$7.34$73,400.0014,500View SEC Filing  
4/6/2015Samuel J GestenVPSell3,223$7.14$23,012.22View SEC Filing  
3/3/2015Robin HughesVPSell23,253$15.82$367,862.46View SEC Filing  
11/19/2014Broadwood Partners LpMajor ShareholderBuy189,646$8.64$1,638,541.44View SEC Filing  
11/18/2014Broadwood Partners LpMajor ShareholderBuy39,400$8.67$341,598.00View SEC Filing  
11/17/2014Broadwood Partners LpMajor ShareholderBuy118,200$8.63$1,020,066.00View SEC Filing  
11/10/2014Broadwood Partners LpMajor ShareholderBuy500$8.79$4,395.00View SEC Filing  
11/7/2014Broadwood Partners LpMajor ShareholderBuy80,000$8.92$713,600.00View SEC Filing  
11/4/2014Broadwood Partners LpMajor ShareholderBuy260,341$9.20$2,395,137.20View SEC Filing  
5/15/2014John MooreDirectorSell2,800$14.87$41,636.0076,000View SEC Filing  
3/19/2014James FranceseVPSell16,666$17.22$286,988.5221,960View SEC Filing  
3/17/2014Robin HughesVPSell5,672$16.61$94,211.9256,818View SEC Filing  
9/4/2013Deborah AndrewsCFOSell50,000$12.88$644,000.0036,400View SEC Filing  
8/20/2013Deborah AndrewsCFOSell33,515$11.65$390,449.7536,400View SEC Filing  
8/12/2013Deborah AndrewsCFOSell9,079$11.62$105,497.9822,621View SEC Filing  
8/7/2013Deborah AndrewsCFOSell11,721$11.79$138,190.5924,639View SEC Filing  
5/9/2013Deborah J AndrewsCFOSell5,000$8.96$44,800.00View SEC Filing  
12/11/2012John C MooreDirectorBuy5,000$5.46$27,300.00View SEC Filing  
11/15/2012Broadwood Partners LpMajor ShareholderBuy2,618$5.00$13,090.00View SEC Filing  
11/15/2012Mark B LoganDirectorBuy3,600$5.22$18,792.00View SEC Filing  
11/14/2012Barry G CaldwellCEOBuy5,000$5.04$25,200.00View SEC Filing  
11/2/2012Broadwood Partners LpMajor ShareholderBuy22,572$5.00$112,860.00View SEC Filing  
8/9/2012Barry G CaldwellCEOBuy5,000$6.57$32,850.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

STAAR Surgical (NASDAQ STAA) News Headlines

Source:
DateHeadline
STAAR Surgical to Report Fourth Quarter Results...STAAR Surgical to Report Fourth Quarter Results...
www.benzinga.com - February 15 at 3:38 PM
STAAR Surgical to Report Fourth Quarter Results on February 28, 2018STAAR Surgical to Report Fourth Quarter Results on February 28, 2018
finance.yahoo.com - February 14 at 3:18 PM
STAAR Surgical (STAA) Expected to Post Earnings of $0.03 Per ShareSTAAR Surgical (STAA) Expected to Post Earnings of $0.03 Per Share
www.americanbankingnews.com - February 14 at 3:16 AM
The intraocular lens (IOL) market is projected to reach to USD 4.56 billion by 2022 from estimated USD 3.50 billion in 2017The intraocular lens (IOL) market is projected to reach to USD 4.56 billion by 2022 from estimated USD 3.50 billion in 2017
www.bizjournals.com - February 7 at 5:35 AM
Reviewing STAAR Surgical (STAA) & Steris (STE)Reviewing STAAR Surgical (STAA) & Steris (STE)
www.americanbankingnews.com - February 3 at 5:14 PM
Analysts Anticipate STAAR Surgical (STAA) to Announce $0.03 Earnings Per ShareAnalysts Anticipate STAAR Surgical (STAA) to Announce $0.03 Earnings Per Share
www.americanbankingnews.com - January 28 at 5:12 PM
Zacks: Analysts Expect STAAR Surgical (STAA) Will Post Earnings of $0.03 Per ShareZacks: Analysts Expect STAAR Surgical (STAA) Will Post Earnings of $0.03 Per Share
www.americanbankingnews.com - January 28 at 3:16 AM
STAAR Surgical (STAA) Raised to Sell at BidaskClubSTAAR Surgical (STAA) Raised to Sell at BidaskClub
www.americanbankingnews.com - January 17 at 12:14 AM
Zacks: Analysts Set $17.67 Target Price for STAAR Surgical (STAA)Zacks: Analysts Set $17.67 Target Price for STAAR Surgical (STAA)
www.americanbankingnews.com - January 12 at 11:06 PM
BRIEF-STAAR Surgical Sees ‍Double Digit Revenue Growth In FY 2018 Over 2017BRIEF-STAAR Surgical Sees ‍Double Digit Revenue Growth In FY 2018 Over 2017
www.reuters.com - January 8 at 3:34 PM
STAAR Surgical (STAA) Cut to Strong Sell at BidaskClubSTAAR Surgical (STAA) Cut to Strong Sell at BidaskClub
www.americanbankingnews.com - January 6 at 3:36 PM
ETFs with exposure to STAAR Surgical Co. : December 26, 2017ETFs with exposure to STAAR Surgical Co. : December 26, 2017
finance.yahoo.com - December 26 at 12:49 PM
STAAR Surgical Co. :STAA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017STAAR Surgical Co. :STAA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 4:09 PM
Zacks: Brokerages Anticipate STAAR Surgical (STAA) Will Post Earnings of $0.03 Per ShareZacks: Brokerages Anticipate STAAR Surgical (STAA) Will Post Earnings of $0.03 Per Share
www.americanbankingnews.com - December 25 at 3:22 PM
Critical Comparison: Tandem Diabetes Care (TNDM) and STAAR Surgical (STAA)Critical Comparison: Tandem Diabetes Care (TNDM) and STAAR Surgical (STAA)
www.americanbankingnews.com - December 16 at 3:27 PM
STAAR Surgical Company (STAA) Expected to Announce Earnings of $0.03 Per ShareSTAAR Surgical Company (STAA) Expected to Announce Earnings of $0.03 Per Share
www.americanbankingnews.com - December 7 at 11:32 PM
Analysts Expect STAAR Surgical Company (STAA) to Announce $0.03 Earnings Per ShareAnalysts Expect STAAR Surgical Company (STAA) to Announce $0.03 Earnings Per Share
www.americanbankingnews.com - November 27 at 4:26 PM
STAAR Surgical Company (STAA) VP Sells $99,900.00 in StockSTAAR Surgical Company (STAA) VP Sells $99,900.00 in Stock
www.americanbankingnews.com - November 22 at 2:03 PM
Benchmark Co. Reiterates "Buy" Rating for STAAR Surgical Company (STAA)Benchmark Co. Reiterates "Buy" Rating for STAAR Surgical Company (STAA)
www.americanbankingnews.com - November 20 at 9:50 AM
Canaccord Genuity Boosts STAAR Surgical Company (STAA) Price Target to $20.00Canaccord Genuity Boosts STAAR Surgical Company (STAA) Price Target to $20.00
www.americanbankingnews.com - November 17 at 5:28 PM
STAAR Surgical Announces Webcast of Upcoming Investor and Analyst Day on November 16, 2017STAAR Surgical Announces Webcast of Upcoming Investor and Analyst Day on November 16, 2017
finance.yahoo.com - November 15 at 12:10 PM
Comparing STAAR Surgical (STAA) and Sientra (SIEN)Comparing STAAR Surgical (STAA) and Sientra (SIEN)
www.americanbankingnews.com - November 15 at 1:24 AM
STAARs (STAA) CEO Caren Mason on Q3 2017 Results - Earnings Call TranscriptSTAAR's (STAA) CEO Caren Mason on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 11:11 AM
EARNINGS SUMMARY: Details of STAAR Surgical Company Q3 Earnings ReportEARNINGS SUMMARY: Details of STAAR Surgical Company Q3 Earnings Report
www.rttnews.com - November 10 at 11:11 AM
Zacks: STAAR Surgical Company (STAA) Given Consensus Rating of "Buy" by BrokeragesZacks: STAAR Surgical Company (STAA) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - November 9 at 3:52 PM
STAAR Surgical Company to Host Earnings CallSTAAR Surgical Company to Host Earnings Call
finance.yahoo.com - November 9 at 2:02 PM
STAAR Surgical Reports Third Quarter 2017 ResultsSTAAR Surgical Reports Third Quarter 2017 Results
finance.yahoo.com - November 9 at 2:02 PM
Staar Surgical posts 3Q profitStaar Surgical posts 3Q profit
finance.yahoo.com - November 9 at 2:02 PM
Edited Transcript of STAA earnings conference call or presentation 8-Nov-17 9:30pm GMTEdited Transcript of STAA earnings conference call or presentation 8-Nov-17 9:30pm GMT
finance.yahoo.com - November 9 at 2:02 PM
STAAR Surgical Company (STAA) Announces Quarterly  Earnings ResultsSTAAR Surgical Company (STAA) Announces Quarterly Earnings Results
www.americanbankingnews.com - November 8 at 7:56 PM
$0.02 EPS Expected for STAAR Surgical Company (STAA) This Quarter$0.02 EPS Expected for STAAR Surgical Company (STAA) This Quarter
www.americanbankingnews.com - October 30 at 3:24 PM
STAAR Surgical to Report Third Quarter Results on November 8, 2017STAAR Surgical to Report Third Quarter Results on November 8, 2017
finance.yahoo.com - October 25 at 11:14 AM
STAAR Surgical Company (STAA) Set to Announce Earnings on WednesdaySTAAR Surgical Company (STAA) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - October 25 at 5:44 AM
Ophthalmic Surgical Technologies Market to Grow due to Growing Adoption of Robotic Surgical InstrumentationOphthalmic Surgical Technologies Market to Grow due to Growing Adoption of Robotic Surgical Instrumentation
globenewswire.com - October 24 at 10:36 AM
STAAR Surgical Company (STAA) Given New $15.00 Price Target at Benchmark Co.STAAR Surgical Company (STAA) Given New $15.00 Price Target at Benchmark Co.
www.americanbankingnews.com - October 21 at 12:38 AM
Zacks Investment Research Lowers STAAR Surgical Company (STAA) to HoldZacks Investment Research Lowers STAAR Surgical Company (STAA) to Hold
www.americanbankingnews.com - October 11 at 8:28 PM
Short Interest Declines 16.4% For STAAShort Interest Declines 16.4% For STAA
www.thestreet.com - October 11 at 3:27 PM
$0.02 Earnings Per Share Expected for STAAR Surgical Company (STAA) This Quarter$0.02 Earnings Per Share Expected for STAAR Surgical Company (STAA) This Quarter
www.americanbankingnews.com - October 11 at 2:16 PM
Canaccord Genuity Reaffirms Buy Rating for STAAR Surgical Company (STAA)Canaccord Genuity Reaffirms Buy Rating for STAAR Surgical Company (STAA)
www.americanbankingnews.com - October 9 at 2:34 PM
STAAR Surgical (STAA) & The Competition Head-To-Head ReviewSTAAR Surgical (STAA) & The Competition Head-To-Head Review
www.americanbankingnews.com - October 7 at 12:18 AM
STAAR Surgical Appoints Scott D. Barnes, M.D. as Chief Medical OfficerSTAAR Surgical Appoints Scott D. Barnes, M.D. as Chief Medical Officer
finance.yahoo.com - October 3 at 12:59 PM
STAAR Surgical (STAA) versus Haemonetics Corporation (HAE) Critical ComparisonSTAAR Surgical (STAA) versus Haemonetics Corporation (HAE) Critical Comparison
www.americanbankingnews.com - October 2 at 12:22 AM
STAAR Surgical Names Deborah Andrews as CFO - PR Newswire (press release)STAAR Surgical Names Deborah Andrews as CFO - PR Newswire (press release)
www.prnewswire.com - September 29 at 7:46 AM
DexCom (DXCM) vs. STAAR Surgical (STAA) Head-To-Head AnalysisDexCom (DXCM) vs. STAAR Surgical (STAA) Head-To-Head Analysis
www.americanbankingnews.com - September 28 at 2:28 PM
STAAR Surgical Names Deborah Andrews as CFOSTAAR Surgical Names Deborah Andrews as CFO
www.bizjournals.com - September 28 at 12:05 PM
STAAR Surgical Company (STAA) Upgraded to "Buy" by Canaccord GenuitySTAAR Surgical Company (STAA) Upgraded to "Buy" by Canaccord Genuity
www.americanbankingnews.com - September 26 at 12:28 AM
ETFs with exposure to STAAR Surgical Co. : September 22, 2017ETFs with exposure to STAAR Surgical Co. : September 22, 2017
finance.yahoo.com - September 23 at 8:48 AM
STAAR Surgical (STAA) & Bio-Rad Laboratories (BIO) Head-To-Head ContrastSTAAR Surgical (STAA) & Bio-Rad Laboratories (BIO) Head-To-Head Contrast
www.americanbankingnews.com - September 16 at 4:42 AM
STAAR Surgical (STAA) & The Competition Head to Head ReviewSTAAR Surgical (STAA) & The Competition Head to Head Review
www.americanbankingnews.com - September 12 at 12:28 AM
STAAR Surgical Company (STAA) Stock Rating Reaffirmed by Canaccord GenuitySTAAR Surgical Company (STAA) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - September 10 at 10:10 PM

SEC Filings

STAAR Surgical (NASDAQ:STAA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

STAAR Surgical (NASDAQ:STAA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

STAAR Surgical (NASDAQ STAA) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.